BIOCOMPATIBLES UK LIMITED

• ⚠

  Material uncertainty over going concern

  The Company is working to transfer the manufacture of Varithena® to Boston Scientific Limited, an Irish BSC Group company that operates several manufacturing facilities in Ireland. Although this work is progressing, completing the transfer has taken longer than expected with completion of the transfer now expected in the second half of 2026. Following the transfer, it is anticipated that the Company will be prepared for a voluntary strike-off. In these circumstances it is not appropriate to prepare the financial statements on a going concern basis. Therefore, the financial statements have been prepared on the basis other than going concern.

1. BIOCOMPATIBLES UK LIMITED 2001-11-28 → present
2. HACKREMCO (NO.1879) LIMITED 2001-10-16 → 2001-11-28

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The Company is working to transfer the manufacture of Varithena® to Boston Scientific Limited, an Irish BSC Group company that operates several manufacturing facilities in Ireland. Although this work is progressing, completing the transfer has taken longer than expected with completion of the transfer now expected in the second half of 2026. Following the transfer, it is anticipated that the Company will be prepared for a voluntary strike-off. In these circumstances it is not appropriate to prepare the financial statements on a going concern basis. Therefore, the financial statements have been prepared on the basis other than going concern.”

Significant events

• “in June 2024 United Healthcare, one of the largest insurance providers in the US, updated its Commercial Policy for Surgical and Ablative Procedures for Venous Insufficiency and Varicose Veins to include Varithena®.”
• “On 20 December 2023, the shares of the Company were sold by BTG International (Holdings) Limited to the BSC Group company BTG Limited.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +0.5%

  £16,994,000 → £17,079,000

• Cash

  +7.6%

  £646,000 → £695,000

• Net assets

  -79.8%

  £61,361,000 → £12,367,000

• Employees

  -5%

  101 → 96

• Operating profit

  -45.2%

  £1,919,000 → £1,051,000

• Profit before tax

  +47.6%

  £1,627,000 → £2,402,000

• Wages

  +9.1%

  £6,673,000 → £7,277,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers